The CAMRIS International and Global Med Technologies(R) Team is Awarded the Phase-II Contract for U.S. Air Force and Armed Servi
October 02 2008 - 9:00AM
PR Newswire (US)
Partnership's Custom Built Solution Advances Toward
Commercialization and Roll-Out for Department of Defense DENVER,
Colo., Oct. 2 /PRNewswire-FirstCall/ -- CAMRIS International, a
professional services firm that provides expert technical resources
and innovative technologies ("CAMRIS"), and Global Med
Technologies(R), Inc. ("Global Med") (OTC:GLOB) (BULLETIN BOARD:
GLOB) , an international e-Health, medical information technology
company, today announced the award and advancement to the next
phase for a project to develop and commercialize a global profile
database to track blood donor identity, health and travel history
for the U.S. Military worldwide. Terms of the agreement were not
disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Major
Ileana Hauge, Chief of Applied Toxicology Research at
Wright-Patterson Air Force Base, stated, "The U.S. Air Force has
realized for some time that a commercial off-the-shelf solution to
manage the Armed Services Blood Program is impractical. CAMRIS and
Wyndgate have demonstrated that a custom solution built to our
specific needs from the backbone of the El Dorado Donor(TM), Donor
Doc(TM) and SafeTrace(R) platforms is the winning alternative.
These vendors have demonstrated their merit and we have confidence
in the outcome as we progress through Phase-II." CAMRIS has
partnered with Global Med's Wyndgate Technologies(R) division since
2006. Last year, under a Department of Defense Small Business
Innovation Research (SBIR) Program, the partnership won a Phase-I
competitive bid, demonstrating the scientific and technical merit
and feasibility of developing a global software system to provide
universal access to donor identity, deferrals and travel history.
The goal is to create continuity across blood bank facilities,
thereby helping to increase the safety of the Armed Forces' global
blood supply. Phase-I included demonstration of a prototype
solution modeled after the platform of Wyndgate's El Dorado Donor,
Donor Doc, and SafeTrace solutions. After winning the Phase-I
award, the companies submitted and recently won a joint proposal to
continue the project in Phase-II, to customize the software for
clinical settings to support robust, accurate and consistent
performance and provide a secure interface to be used worldwide.
The Phase-II award is significant in that it advances the project
from prototype through development, culminating in potential
commercialization and roll-out. Merits of the Phase-II advancement
include confidence from the Air Force and Armed Services Blood
Program that the project has technical and scientific merit, that
commercial application is promising, and that there is evidence of
the competency and qualifications of the principal investigator
team to deliver results. Ultimately, the software solution may be
employed to fulfill the needs not only of the U.S. Air Force, U.S.
Navy and U.S. Army, but also of NATO alliance countries as the need
to track and move blood increases with globalization of services.
After an extensive evaluation by the Wright Patterson Air Force
Research Laboratory, an independent report determined that CAMRIS
and Wyndgate exhibited dedicated technical and professional
resources committed to the SBIR project, and that their software
products were proven in the industry and trusted by blood bankers.
The partners also possess a broad continuum of knowledge about
SBIR. In addition, the evaluation concluded that CAMRIS and
Wyndgate have proven project management and blood computer database
system implementation and support experience and have the
documented ability to deliver solutions that solve complex and
diverse business needs that will be needed globally in the Armed
Forces and with NATO. Carlos Rivera, CEO of CAMRIS International,
stated, "We believe the CAMRIS/Wyndgate team has a unique
combination of experience in health care, technological innovation,
and support for the Armed Forces. Mr. Rivera continued, "We are
confident that this will be the perfect opportunity to combine our
capabilities and continue into a future Phase-III in which the
solution has the potential to be commercialized among all
government agencies domestically and internationally." Mick Ruxin,
M.D., Chairman and CEO of Global Med Technologies, Inc., stated,
"We are proud to advance to Phase-II with this SBIR." Dr. Ruxin
continued, "The confidence placed in us by the Department of
Defense is a testament to our commitment to help the U.S. Armed
Forces and NATO to provide safety and security for the global
military blood supply. We are excited to add yet another dimension
to our global footprint as we move forward with CAMRIS and the
dedicated individuals at Wright Patterson Air Force Base." About
CAMRIS International CAMRIS delivers comprehensive and customized
services in the areas of knowledge management, public health,
international development, medical services and technology
solutions. CAMRIS is a unique, fast growing, dynamic small business
and has project experience spanning more than 1,300 completed tasks
and activities for more than 300 clients over the past 50 years.
CAMRIS International is a certified 8(a), Service Disabled Veteran
Owned, and a certified Maryland MBE, facility-cleared, small
disadvantaged business. For more information about CAMRIS
International, please call (301) 770-6000 or visit
http://www.camrisinternational.com/ or http://www.camris.net/ About
Global Med Technologies, Inc. Global Med Technologies(R), Inc. is
an international medical software company which develops regulated
and non-regulated software products and services for the healthcare
industry. As a leading provider of blood and laboratory software
applications and services, Global Med's products are deployed in 20
countries and serve over 1,600 transfusion centers, blood banks and
laboratories. Global Med's U.S. division, Wyndgate Technologies(R),
provides Vein-to-Vein(R) tracking through its Donor Doc(TM),
SafeTrace(R), SafeTrace Tx(R) and El Dorado Donor(TM) software
products. Each year, Wyndgate's products and services manage more
than eight million blood components, representing over 27% of the
U.S. blood supply. Global Med's European subsidiary, Inlog, SA, is
a leading provider of donor center and transfusion management
systems as well as cellular therapy software, laboratory
information systems and quality assurance medical software systems
internationally. Inlog's products include EdgeBlood*, EdgeTrack*,
EdgeCell, EdgeLab and SAPA. Global Med's U.S. division, eDonor(R),
provides a web-based donor relationship management system that
integrates recruitment, scheduling, retention and fulfillment for
national as well as local community blood centers and hospitals.
eDonor's products and services are designed to complement Global
Med's strong line of international blood management and laboratory
information software and service solutions. Global Med's U.S.
subsidiary, PeopleMed(R), Inc., provides cost-effective customized
software validation, consulting and compliance solutions to
hospitals and donor centers. For more information about Global
Med's products and services, please call 800-996-3428 or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/,
http://www.inlog.com/, http://www.edonor.com/, and
http://www.wyndgate.com/. *FDA 510(k) clearance required prior to
sales in the U.S. This news release may include statements that
constitute forward-looking statements, usually containing the words
"believe," "estimate," "project," "expects" or similar expressions.
These statements are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Carlos Rivera, CEO, +1-301-770-6000, ext. 106, , or
Dr. Maria Trujillo, Principal Investigator, +1-301-770-6000, ext.
131, , both of CAMRIS International; or Michael I. Ruxin, M.D. of
Global Med Technologies, Inc., +1-303-238-2000, ; or Investors,
Paul Holm, President of portfolio pr. +1-212-888-4570, , for Global
Med Technologies, Inc. Web site: http://www.globalmedtech.com/
http://www.wyndgate.com/ http://www.camrisinternational.com/
http://www.camris.net/
Copyright